Global R&D Efforts To Address Emerging Infectious Diseases Should Build Upon Lessons From U.S. Biodefense Product Development
News Summary
Nature Biotechnology: Preparing for the next Zika Kendall Hoyt, assistant professor at the Geisel School of Medicine at Dartmouth, and Richard Hatchett, acting director of the Biomedical Advanced Research and Development Authority “…The development of new biomedical countermeasures — vaccines, therapies, and diagnostic — requires the coordination of a wide…